Emcure Pharmaceuticals' Emcutix Acquires Exclusive Rights to Sell PRX-Plus in India Under Licensing Agreement with WiQo

Unknown Apr 02, 2026 3 Views

Emcure Pharmaceuticals, one of the Indian pharma industry's top names, has reported that its dermatology business unit, Emcutix, has acquired exclusive rights for selling PRX-Plus in India. The achievement has come as part of an exclusive licensing agreement inked between Emcutix and Italian...